Android app on Google Play

Clovis Oncology (CLVS) Prices 3.75M Offering at $20/Share

April 4, 2012 6:27 AM EDT Send to a Friend
Clovis Oncology, Inc. (Nasdaq: CLVS) announces the pricing of its underwritten public offering of 3,750,000 shares of its common stock at $20.00 per share, before underwriting discounts and commissions.

In addition, the underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock from Clovis Oncology to cover over-allotments, if any.

The offering is expected to close on April 10, 2012, subject to customary closing conditions.




You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Add Your Comment